| Dr Patricia L Paddison, MD | |
|
1400 112th Ave Se; Suite 100, Bellevue, WA 98004-6997 | |
| (425) 455-2526 | |
| (425) 484-2200 |
| Full Name | Dr Patricia L Paddison |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1400 112th Ave Se; Suite 100, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750475307 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 28129 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia L Paddison, MD 1400 112th Ave Se; Suite 100, Bellevue, WA 98004-6997 Ph: (425) 455-2526 | Dr Patricia L Paddison, MD 1400 112th Ave Se; Suite 100, Bellevue, WA 98004-6997 Ph: (425) 455-2526 |
News Archive
Despite clean water and improved public services, water-related diseases continues to spread in cities around the world. Vanier Canada Graduate Scholar Kate Mulligan presents her research on the connection between cities, water and health at the THINK CANADA Press Breakfast at the American Association for the Advancement of Science conference Sunday.
Infectious organisms that become resistant to antibiotics are a serious threat to human society. They are also a natural part of evolution. In a new project, researchers at the University of Gothenburg are attempting to find substances that can slow the pace of evolution, in order to ensure that the drugs of today remain effective into the future.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced initiation of patient enrollment in the second Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients with secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease.
New York City's ban on large sugary drinks will get an appeal hearing in June after a judge struck down the law before it started being enforced.
› Verified 4 days ago
Ted W Farrand, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-1331 | |
Dr. Ashok Shimoji-krishnan, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-3802 | |
Dr. Romelia Perez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1611 116th Ave Ne, Suite 132, Bellevue, WA 98004 Phone: 206-795-9797 | |
Dr. Richard Cecil Geary Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1750 112th Ave Ne, B102, Bellevue, WA 98004 Phone: 425-688-5460 Fax: 425-739-4667 | |
Dr. Edward William Freedman, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1621 114th Ave Se, Suite 221, Bellevue, WA 98004 Phone: 425-455-9900 Fax: 425-688-9987 | |
Ms. Claire Pastor, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se Ste 100, Bellevue, WA 98004 Phone: 425-462-9511 Fax: 425-462-8894 | |
Dr. Megan Christine Riddle, MD PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1231 116th Ave Ne Ste 350, Bellevue, WA 98004 Phone: 425-454-1010 Fax: 425-880-5816 |